Article
Epidemiology of drug-resistant malaria in Republic of Congo: using molecular evidence for monitoring antimalarial drug resistance combined with assessment of antimalarial drug use.
Tropical medicine & international health : TM & IH - 1 Oct 2005
Nsimba Basile, Jafari-Guemouri Sayeh, Malonga David A, Mouata André M, Kiori Jeannine, Louya Frédéric, Yocka Dominique, Malanda Maurice, Durand Rémy, Le Bras Jacques
Abstract excerpt
In Congo, urgent efforts are needed to help with the revision of the national antimalarial drug policy. Despite its high resistance level, chloroquine (CQ) is still extensively used as the first-line treatment for uncomplicated Plasmodium falciparum malaria. The study was conducted in children under 5 years with uncomplicated malaria in Pointe-Noire and Brazzaville, the two largest cities that contain...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
